International Consortium of Meningiomas (ICOM) Education Day
The International Consortium on Meningiomas (ICOM) is hosting a joint NASBS/ICOM scientific day on Thursday, March 5th. Led by Dr. Gelareh Zadeh, this consortium was formed to increase awareness for this understudied disease and conduct world-class research through international and multidisciplinary collaboration. This meeting’s program will focus on cutting-edge topics including augmented reality for complex surgical planning, intraoperative molecular diagnosis, artificial intelligence for surgical safety and outcome prediction, modern surgical approaches, novel molecular biomarkers, and many others. The sessions will be highly relevant to anyone involved in meningioma or artificial intelligence research and/or anyone who takes care of patients with brain tumors. Please note: this day is a non-CME educational program.
ICOM Organizing Committee: Alex Landry, Farshad Nassiri, Gelareh Zadeh, Michael Ivan, Paul Gardner
AGENDA:
8:00 AM – 8:05 AM Welcome and Overview of ICOM: Meningioma Consortium
PRE-OP: Seeing The Unseeable
8:05 AM – 8:20 AM Noninvasive Imaging for Meningioma: What we can learn
8:20 AM – 8:30 AM Deep Learning of Magnetic Resonance Imaging for Molecular Classification of Meningiomas
8:30AM – 8:45 AM Natural History of Meningiomas
8:45 AM – 9:00 AM Progesterone Therapy in Meningioma Management
9:00 AM – 9:15 AM Preoperative DOTATATE PET Imaging for Meningioma Surgical Planning
INTRA-OP: Surgical Innovation for Patient Safety
9:15 AM – 9:30 AM Development and Validation of a Quality of Life Questionnaire for Meninigoma
9:30 AM – 9:45 AM Discussion
9:45 AM – 10:00 AM Break
10:00 AM – 10:15 AM Augmented Reality & 3D Modelling for Surgical Planning
10:15 AM – 10:30 AM Endoscopic Transorbital Approach to Sphenoid Wing, Spheno-Orbital, and Middle Fossa Meningiomas
10:30 AM – 10:45 AM Endoscopic decompression of cavernous meningiomas presenting with diplopia
10:45 AM – 11:00 AM Can’t Spell Meningioma without AI: how surgical data science can improve patient care
11:00 AM – 11:15 AM Surgeon-Centric Intra-operative AI Assistance – Iterative Development & Systematic Evaluation
11:15 AM – 11:30 AM Approach Selection and Technical Nuances for Suprasellar Meningiomas
11:30 AM – 11:45 AM Corridors of Approach: The Modern Approach to Skull Base Meningioma Surgery
11:45 AM – 12:00 PM Label-free Intraoperative Meningioma Diagnosis Using Stimulated Raman Histology
12:00 PM – 12:15 PM Discussion
12:15PM – 1:00PM Lunch
PANEL / CASES
1:00PM – 2:00PM Tumor Board: Experts vs AtlasGPT
POST-OP: Personalized Therapy for Improved Outcomes
2:00 PM – 2:15 PM Deep learning for molecular classification of meningioma with H&E
2:15 PM – 2:30 PM TBD
2:30 PM – 2:45 PM Local Delivery of Chemotherapies via Bioresorbable Implants in Aggressive Meningiomas
2:45 PM – 3:00 PM Ga-DOTATATE PET as an Imaging Biomarker in Meningioma
3:00 PM – 3:15 PM NRG-BN015: A randomized phase 3 clinical trial of postoperative radiotherapy versus postoperative surveillance for clinical low-risk, molecular high-risk meningioma and longitudinal surveillance for clinical and molecular low-risk meningioma
3:15 PM – 3:30 PM Immunotherapy in Meningioma
3:30 PM – 3:45 PM Discussion
3:45 PM – 4:00 PM Break
Building a Skull Base Career
4:00 PM – 4:15 PM Lessons Learned in Building an Academic Skull Base Practice
4:15 PM – 4:30 PM The Other Academic Path: Building Skull Base Success in a Community Setting
4:30PM – 4:45 PM The Long Game: Strategic Thinking for a Career in Skull Base Surgery
4:45 PM – 5:00PM Discussion
5:00 PM – 6:00 PM Proffered Papers (submit your abstract below)
SUBMIT YOUR ICOM ABSTRACT HERE